A comprehensive view of moderna inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

COVID-19 vaccine makers prepare for smaller booster vaccine market as demand for first shots falls; global booster shot market, including people over 50, adults with health risk factors or who work in high-risk occupations, estimated at 1.7 billion people
Published: May 10, 2022 by CE Noticias Financieras
Commentary: mRNA technology used by Pfizer, Moderna for COVID vaccines could end up unlocking much more for future of health care; numerous mRNA vaccine candidates are being researched, undergoing clinical trials for treating cancer, HIV, flu, ebola, more
Published: May 09, 2022 by Bay City Times
Moderna reports Q1 net profit up at US$3.7B from US$1.2B a year ago, with total revenue up at US$6.1B from US$1.9B a year ago, as COVID-19 vaccine sales jump to US$5.9B from US$1.7B a year ago; bivalent COVID-19 booster vaccine currently in Phase2/3 study
Published: May 06, 2022 by SeeNews Pharmaceuticals
Moderna to build vaccine production facility in Montreal, Quebec, to open in 2024 as part of Canadian government’s billion dollar investment to rebuild vaccine production in the country; Moderna also building vaccine plant in Melbourne, Australia
Published: April 29, 2022 by Canadian Press DataFile
Moderna request emergency use authorization in US for its COVID-19 vaccination for kids aged six months to six years in two 25 mg doses, with Moderna aiming for June vaccine roll-out; children under five have very low risk of developing severe disease
Published: April 28, 2022 by AFP World News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count